| Identification | Back Directory | [Name]
Palbociclib-025 | [CAS]
2174002-16-3 | [Synonyms]
Palbociclib E
N-Formyl Palbociclib
Palbociclib Impurity 025
1-Piperazinecarboxaldehyde, 4-[6-[(6-acetyl-8-cyclopentyl-7,8-dihydro-5-methyl-7-oxopyrido[2,3-d]pyrimidin-2-yl)amino]-3-pyridinyl]-
4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carbaldehyde? (Palbociclib Impurity）
Palbociclib impurity 27/Palbociclib N-Formyl Impurity/4-(6-((6-acetyl-8-cyclopentyl-5-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-yl)amino)pyridin-3-yl)piperazine-1-carbaldehyde | [Molecular Formula]
C25H29N7O3 | [MOL File]
2174002-16-3.mol | [Molecular Weight]
475.54 |
| Chemical Properties | Back Directory | [Boiling point ]
765.3±70.0 °C(Predicted) | [density ]
1.389±0.06 g/cm3(Predicted) | [solubility ]
Chloroform (Slightly), DMSO (Slightly) | [form ]
Solid | [pka]
5.24±0.10(Predicted) | [color ]
Light Yellow to Very Dark Yellow |
| Hazard Information | Back Directory | [Uses]
Palbociclib N-Aldehyde is an intermediate in synthesizing Palbociclib N-b-D-Glucuronide Sodium Salt (P139910), a derivative of Palbociclib (P139900) which is an experimental drug for the treatment of breast cancer being developed by Pfizer. It is a selective inhibitor of the cyclin-dependent kinases CDK4 and CDK6. |
|
| Company Name: |
TOSUN PHARM
|
| Tel: |
020-61855200 13326451905 |
| Website: |
www.toref.cn/ |
|